| Filed On | Filing |
|---|---|
| 02 Sep 2026 |
Form 4: Gold Kelly, Chief Financial Officer
Bought 10,000 shares ($39.6K) |
| 31 Aug 2026 |
Form 4: Schwab Andrew J., Director
Sold 400,000 shares ($1.62M) |
| 26 Aug 2026 |
Form 4: Schwab Andrew J., Director
Sold 10 shares ($45) |
| 21 Aug 2026 |
Form 4: Schwab Andrew J., Director
Sold 45,147 shares ($215K) · Sold 114,700 shares ($521K) · Sold 32,018 shares ($144K) |
| 19 Aug 2026 |
Form 4: Tardiff Daniel, Chief Scientific Officer
Sold 1,738 shares ($8.27K) |
| 05 Aug 2026 |
Form 4: 5AM Partners VI, Llc, 10% owner and 6 others
Acquired 3,179,558 Pre-Funded Warrant (Right to Buy) (Open Market Purchase) ($4.86M) |
| 05 Aug 2026 |
Form 4: Schwab Andrew J., Director
Granted 3,179,558 Pre-Funded Warrant (Right to Buy) ($4.86M) |
| 05 Aug 2026 |
Form 4: Young Richard A, Director
Bought 16,378 shares ($27K) |
| 05 Aug 2026 |
Form 4: Maricich Yuri, Chief Medical Officer
Bought 6,551 shares ($10.8K) |
| 05 Aug 2026 |
Form 4: Gold Kelly, Chief Financial Officer
Bought 6,551 shares ($10.8K) |
| 05 Aug 2026 |
Form 4: Mandel-Brehm Josh, Director
Bought 6,551 shares ($10.8K) |
| 12 Jun 2026 |
Form 4: Williams Douglas E, Director
Granted 28,000 Stock Option (Right to Buy) |
| 12 Jun 2026 |
Form 4: Young Richard A, Director
Granted 28,000 Stock Option (Right to Buy) |
| 12 Jun 2026 |
Form 4: Schwab Andrew J., Director
Granted 28,000 Stock Option (Right to Buy) |
| 12 Jun 2026 |
Form 4: Holtzman Steven H, Director
Granted 28,000 Stock Option (Right to Buy) |
| 12 Jun 2026 |
Form 4: Stewart Murray, Director
Granted 28,000 Stock Option (Right to Buy) |
| 12 Jun 2026 |
Form 4: Nashat Amir, Director
Granted 28,000 Stock Option (Right to Buy) |
| 03 Apr 2026 |
Form 4: Tardiff Daniel, Chief Scientific Officer
Granted 170,000 Stock Option (Right to Buy) |
| 03 Apr 2026 |
Form 4: Maricich Yuri, Chief Medical Officer
Granted 215,000 Stock Option (Right to Buy) |
| 03 Apr 2026 |
Form 4: Gold Kelly, Chief Financial Officer
Granted 215,000 Stock Option (Right to Buy) |
Loading...